Dr Michelle Henderson

Related Grants and Projects

• Participant in Identification of germline variation that predicts progression free survival following chemotherapy for advanced ovarian cancer (funded by National Health and Medical Research Council)
• Principal investigator of New compounds for tailored therapy against MLL-rearranged leukaemia (funded by National Health and Medical Research Council)
• Participant in Targeted inhibition of Multidrug Resistance-associated Protein 4 (MRP4) as a therapeutic strategy for childhood neuroblastoma (funded by National Health and Medical Research Council)